CA2888856A1 - Comprime dispersible - Google Patents
Comprime dispersible Download PDFInfo
- Publication number
- CA2888856A1 CA2888856A1 CA2888856A CA2888856A CA2888856A1 CA 2888856 A1 CA2888856 A1 CA 2888856A1 CA 2888856 A CA2888856 A CA 2888856A CA 2888856 A CA2888856 A CA 2888856A CA 2888856 A1 CA2888856 A1 CA 2888856A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- tablet
- nimorazole
- water
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/680,216 US8703188B1 (en) | 2012-11-19 | 2012-11-19 | Dispersible tablet |
DK201270714A DK177906B1 (en) | 2012-11-19 | 2012-11-19 | Dispersible tablet |
DKPA201270714 | 2012-11-19 | ||
US13/680,216 | 2012-11-19 | ||
PCT/DK2013/050384 WO2014075692A1 (fr) | 2012-11-19 | 2013-11-18 | Comprimé dispersible |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2888856A1 true CA2888856A1 (fr) | 2014-05-22 |
Family
ID=49683383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2888856A Abandoned CA2888856A1 (fr) | 2012-11-19 | 2013-11-18 | Comprime dispersible |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2919754A1 (fr) |
JP (1) | JP2015537013A (fr) |
AU (1) | AU2013347264B2 (fr) |
BR (1) | BR112015011408A2 (fr) |
CA (1) | CA2888856A1 (fr) |
EA (1) | EA201590732A1 (fr) |
MX (1) | MX2015006217A (fr) |
NZ (1) | NZ707033A (fr) |
RU (1) | RU2015117921A (fr) |
TN (1) | TN2015000156A1 (fr) |
WO (1) | WO2014075692A1 (fr) |
ZA (1) | ZA201502896B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2017009681A (es) * | 2015-01-27 | 2017-10-18 | Janssen Pharmaceutica Nv | Composiciones dispersables. |
IL292262B2 (en) | 2015-04-01 | 2024-02-01 | Akebia Therapeutics Inc | Formulation of an oral administration form of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070264330A1 (en) * | 2006-05-15 | 2007-11-15 | Bo Ragnar-Tolf | Pharmaceutical formulations of pimavanserin |
JP2008081448A (ja) * | 2006-09-28 | 2008-04-10 | Kowa Pharmaceutical Co Ltd | 酒石酸ゾルピデムの苦味マスキング速放性粒子 |
US20080131467A1 (en) * | 2006-11-30 | 2008-06-05 | Dennis Nelson | Film-coated solid dosage form |
KR101907218B1 (ko) * | 2009-12-11 | 2018-10-11 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 유핵형 구강내 붕해 정제 |
JP2013530930A (ja) * | 2010-04-14 | 2013-08-01 | ユーファーマ ピーティーワイ リミテッド | 放射線増感剤組成物 |
-
2013
- 2013-11-18 WO PCT/DK2013/050384 patent/WO2014075692A1/fr active Application Filing
- 2013-11-18 RU RU2015117921A patent/RU2015117921A/ru not_active Application Discontinuation
- 2013-11-18 CA CA2888856A patent/CA2888856A1/fr not_active Abandoned
- 2013-11-18 JP JP2015542166A patent/JP2015537013A/ja active Pending
- 2013-11-18 AU AU2013347264A patent/AU2013347264B2/en active Active
- 2013-11-18 EA EA201590732A patent/EA201590732A1/ru unknown
- 2013-11-18 MX MX2015006217A patent/MX2015006217A/es unknown
- 2013-11-18 EP EP13798918.2A patent/EP2919754A1/fr not_active Withdrawn
- 2013-11-18 NZ NZ707033A patent/NZ707033A/en unknown
- 2013-11-18 BR BR112015011408A patent/BR112015011408A2/pt not_active IP Right Cessation
-
2015
- 2015-04-22 TN TNP2015000156A patent/TN2015000156A1/fr unknown
- 2015-04-28 ZA ZA2015/02896A patent/ZA201502896B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2015117921A (ru) | 2017-01-10 |
EP2919754A1 (fr) | 2015-09-23 |
AU2013347264A1 (en) | 2015-05-07 |
TN2015000156A1 (en) | 2016-10-03 |
ZA201502896B (en) | 2016-11-30 |
EA201590732A1 (ru) | 2016-01-29 |
NZ707033A (en) | 2016-11-25 |
JP2015537013A (ja) | 2015-12-24 |
AU2013347264B2 (en) | 2016-10-27 |
MX2015006217A (es) | 2015-11-16 |
WO2014075692A1 (fr) | 2014-05-22 |
BR112015011408A2 (pt) | 2017-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6932746B2 (ja) | エンザルタミドの製剤 | |
TWI778983B (zh) | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 | |
JP6325627B2 (ja) | 口腔内崩壊錠及びその製造方法 | |
JP6041919B2 (ja) | 8−[{1−(3,5−ビス−(トリフルオロメチル)フェニル)−エトキシ}−メチル]−8−フェニル−1,7−ジアザ−スピロ[4.5]デカン−2−オンの塩を含む錠剤処方物およびそれから作製される錠剤 | |
CN100379407C (zh) | 生产咀嚼分散片的方法 | |
TW201000472A (en) | New solid pharmaceutical formulations comprising BIBW 2992 | |
JP2010525082A (ja) | 固体投与形 | |
KR102408085B1 (ko) | 아세트아미노펜 제제의 제조 방법 | |
WO2011071139A1 (fr) | Comprimé enrobé à sec à désintégration orale | |
KR20100099113A (ko) | 만니톨 및/또는 미세결정질 셀룰로스를 포함하는 지보텐탄 조성물 | |
JP2022105754A (ja) | 緩下用錠剤 | |
AU2013347264B2 (en) | Dispersible tablet | |
US8741344B1 (en) | Dispersible tablet | |
CN108420798A (zh) | 一种抗凝剂的速释药物制剂及其制备方法 | |
US20150283083A1 (en) | Dispersible Tablet | |
CN115177595A (zh) | 一种噁拉戈利钠片剂及其制备方法 | |
KR102598782B1 (ko) | 알펠리십을 포함하는 제약 조성물 | |
DK177906B1 (en) | Dispersible tablet | |
JP7250305B2 (ja) | メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法 | |
TW201446287A (zh) | 適合對兒童投予之快速崩解錠及其簡便之製造方法 | |
JP2006022060A (ja) | 制酸・緩下用水分散液およびそのための錠剤 | |
JP2008519834A (ja) | 低水溶性薬物とともに使用することによく適した圧縮固体状投与形態の製造方法およびそれにより製造された圧縮固体状投与形態 | |
KR101625344B1 (ko) | 세레콕시브 및 둘록세틴을 함유하는 약제학적 조성물 | |
TW202333702A (zh) | 具有優異溶出性之醫藥組成物 | |
CN115803020A (zh) | 含有苯磺酸米洛巴林的口腔崩解片剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20150421 |
|
FZDE | Dead |
Effective date: 20190326 |